logo
AAT Bioquest

Opioid receptors; delta & kappa Inhibitors (IC50, Ki)

Structure
Compound Name
Standard Type
Standard Values (in nM)
N'-[2-[[2-[[(1S,2S,13R,21R)-22-(Cyclopropylmethyl)-2,16-dihydroxy-14-oxa-11,22-diazaheptacyclo[13.9.1.01,13.02,21.04,12.05,10.019,25]pentacosa-4(12),5(10),6,8,15,17,19(25)-heptaen-9-yl]amino]-2-oxoethyl]amino]-2-oxoethyl]-N-[2-[[2-[3-[(1S)-1-[[2-(3,4-dichlorophenyl)acetyl]-methylamino]-2-pyrrolidin-1-ylethyl]anilino]-2-oxoethyl]amino]-2-oxoethyl]butanediamideKi0.52 [1]
N'-[2-[[(1S,2S,13R,21R)-22-(Cyclopropylmethyl)-2,16-dihydroxy-14-oxa-11,22-diazaheptacyclo[13.9.1.01,13.02,21.04,12.05,10.019,25]pentacosa-4(12),5(10),6,8,15,17,19(25)-heptaen-9-yl]amino]-2-oxoethyl]-N-[2-[3-[(1S)-1-[[2-(3,4-dichlorophenyl)acetyl]-methylamino]-2-pyrrolidin-1-ylethyl]anilino]-2-oxoethyl]butanediamideKi1.9 [1]
N'-[2-[[2-[3-[(1S)-1-[[2-(3,4-Dichlorophenyl)acetyl]-methylamino]-2-pyrrolidin-1-ylethyl]anilino]-2-oxoethyl]amino]-2-oxoethyl]-N-[2-[[2-(methylamino)-2-oxoethyl]amino]-2-oxoethyl]butanediamideKi23.9 [1], 36.2 [2], 1000.0 [3]
N'-[2-[3-[(1S)-1-[[2-(3,4-Dichlorophenyl)acetyl]-methylamino]-2-pyrrolidin-1-ylethyl]anilino]-2-oxoethyl]-N-[2-(methylamino)-2-oxoethyl]butanediamideKi6.75 [1], 41.6 [2], 281.2 [3], 1000.0 [4]
N'-[2-[[(1S,2S,13R,21R)-22-(Cyclopropylmethyl)-2,16-dihydroxy-14-oxa-11,22-diazaheptacyclo[13.9.1.01,13.02,21.04,12.05,10.019,25]pentacosa-4(12),5(10),6,8,15,17,19(25)-heptaen-9-yl]amino]-2-oxoethyl]-N-[2-(methylamino)-2-oxoethyl]butanediamideKi0.15 [1], 0.46 [2], 1000.0 [3]
N'-[2-[[2-[[(1S,2S,13R,21R)-22-(Cyclopropylmethyl)-2,16-dihydroxy-14-oxa-11,22-diazaheptacyclo[13.9.1.01,13.02,21.04,12.05,10.019,25]pentacosa-4(12),5(10),6,8,15,17,19(25)-heptaen-9-yl]amino]-2-oxoethyl]amino]-2-oxoethyl]-N-[2-[[2-(methylamino)-2-oxoethyl]amino]-2-oxoethyl]butanediamideKi0.91 [1], 1.07 [2], 1000.0 [3]
NaltrexoneKi0.04 [1]
NaltrindoleKi50.5 [1]
(1S,2R,13R)-13,22-Dimethyl-2-[(E)-3-phenylprop-2-enyl]-14-oxa-11,22-diazaheptacyclo[13.9.1.01,13.02,21.04,12.05,10.019,25]pentacosa-4(12),5,7,9,15,17,19(25)-heptaen-16-olKi7.5 [1]
(1S,10S,14S,18E)-18-Benzylidene-3-hydroxy-4-methoxy-17-methyl-17-azapentacyclo[7.5.3.210,14.01,10.02,7]nonadeca-2(7),3,5-trien-13-oneKi0.04 [1]
(1S,2R,13R)-13,22-Dimethyl-2-(3-methylbut-2-enyl)-14-oxa-11,22-diazaheptacyclo[13.9.1.01,13.02,21.04,12.05,10.019,25]pentacosa-4(12),5,7,9,15,17,19(25)-heptaen-16-olKi8.6 [1]
(1S,2S,13R)-19-Methoxy-24-methyl-26-propan-2-ylidene-4,24-diazaheptacyclo[12.7.3.22,13.01,13.03,11.05,10.016,21]hexacosa-3(11),5,7,9,16(21),17,19-heptaen-20-olKi0.3 [1]
(1S,10S,14S,18E)-3-Hydroxy-4-methoxy-17-methyl-18-(1-phenylethylidene)-17-azapentacyclo[7.5.3.210,14.01,10.02,7]nonadeca-2(7),3,5-trien-13-oneKi0.02 [1]
(1S,2S,13R,26E)-26-Benzylidene-19-methoxy-24-methyl-4,24-diazaheptacyclo[12.7.3.22,13.01,13.03,11.05,10.016,21]hexacosa-3(11),5,7,9,16(21),17,19-heptaen-20-olKi2.2 [1]
(1S,2S,13R,26E)-19-Methoxy-24-methyl-26-(1-phenylethylidene)-4,24-diazaheptacyclo[12.7.3.22,13.01,13.03,11.05,10.016,21]hexacosa-3(11),5,7,9,16(21),17,19-heptaen-20-olKi0.03 [1]
(1S,2S,13R,26E)-26-Ethylidene-19-methoxy-24-methyl-4,24-diazaheptacyclo[12.7.3.22,13.01,13.03,11.05,10.016,21]hexacosa-3(11),5,7,9,16(21),17,19-heptaen-20-olKi2.9 [1]



References

This online tool may be cited as follows

MLA

"Quest Database™ Opioid receptors; delta & kappa Inhibitors (IC50, Ki)." AAT Bioquest, Inc.21 Dec2024https://www.aatbio.com/data-sets/opioid-receptors-delta-kappa-inhibitors-ic50-ki.

APA

AAT Bioquest, Inc. (2024December 21). Quest Database™ Opioid receptors; delta & kappa Inhibitors (IC50, Ki). AAT Bioquest. https://www.aatbio.com/data-sets/opioid-receptors-delta-kappa-inhibitors-ic50-ki.
BibTeXEndNoteRefMan